Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

GenomtecTumor

Financiado

Cerrado

MicroRNA based tool for non invasive early stage cancer diagnosis

The goal of this project is to develop a portable and easy to use device for early cancer diagnosis to maximise patient outcomes. Cancer is a major public health problem and a leading cause of morbidity and death with over 14.1 mi... ver más

30/04/2020

Genomtec S.A.

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

GENOMTEC SPOLKA AKCYJNA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2020-04-30

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

Genomtec S.A.

50.00K€ | Lider

HOME 24 POR 7

493.76K€ | Participante

Proyectos interesantes

LIVELMIA

Medical Technol...

Data Science

71K€ Cerrado

MiRACLE

Medical Technol...

Data Science

Cerrado

KSI 20090005 ANALIZADOR CLÍNICO AUTOMÁTICO...

Medical Technol...

Data Science

1M€ Cerrado

AI-MICADIS

Medical Technol...

Data Science

71K€ Cerrado

PORTFASTFLU

Medical Technol...

Data Science

4M€ Cerrado

miRNA-DisEASY

Medical Technol...

Data Science

491K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 4 meses Fecha Inicio: 2019-12-03
Fecha Fin: 2020-04-30

Líder del proyecto

GENOMTEC SPOLKA AKCYJNA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The goal of this project is to develop a portable and easy to use device for early cancer diagnosis to maximise patient outcomes. Cancer is a major public health problem and a leading cause of morbidity and death with over 14.1 million cases reported worldwide every year. Early cancer diagnosis is critical to its successful treatment, yet today’s technologies are limited in their accuracy, and are laborious and time consuming processes. Genomtec aims to address this challenge with its novel diagnostic system based on unique, patent pending amplification technology – Streamlined Nucleic Acid Amplification Technology (SNAATTM). Genomtec’s programme is built on many years of R&D activity and collaborative projects with academic and medical institutions in Poland. Using this robust molecular biology method for real-time amplification of nucleic acids, Genomtec’s cancer diagnostic test can be performed in 20 minutes at the point-of-care. Genomtec offers the possibility to accurately diagnose cancer early and reduce its financial burden on the economy by enabling more effective treatment and improved patient outcomes, including increased patient survival, increased post-treatment quality of life, and reduced patient distress during the diagnostic phase. Genomtec’s diagnostic device is unique and there are no competitors using the same molecular approach to diagnose cancer based on detection of tumour specific microRNA. The ultimate success of this project will depend on the generation of clinical data which will improve opportunities for sales expansion. Genomtec plans to apply for the SME Phase 2 grant to take its product through device finalisation, clinical studies, and establishment of the distribution network. Genomtec has an established business development contact network and has been awarded numerous prizes for its innovativeness and potential for growth, e.g. The best non-US startup at Boston HUBWeek in October 2018.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores